Literature DB >> 3105836

Calcium phosphate saturation levels in ultrafiltered serum.

N Eidelman, L C Chow, W E Brown.   

Abstract

Calcifications occurring in arteriosclerotic plaque and other pathological deposits are important health concerns, and the nature of these deposits and their mechanisms of formation warrant investigation. Crystals of the relevant calcium phosphates were equilibrated with the undiluted ultrafiltered human serum (u.f.s.) at 37 degrees C by constant stirring and periodically removing samples for calcium and phosphate analysis and for pH measurement. The solubility measurements were carried out both with and without a 5.5% CO2 atmosphere, the physiological partial pressure of CO2. The apparent ion activity products of well-crystallized dicalcium phosphate dihydrate (DCPD), octacalcium phosphate (OCP), and hydroxyapatite (OHAp) equilibrated in u.f.s. were calculated from the calcium and phosphate concentrations and pH in each case for comparison with their known solubility products. In this way the well-crystallized calcium phosphates serve as fiducial solubility standards, thereby minimizing errors due to complexing of calcium and phosphate ions by u.f.s. constituents. Under 5.5%, CO2 native u.f.s. was found to be substantially undersaturated with respect to DCPD, slightly supersaturated with respect to OCP, and highly supersaturated with respect to OHAp. The ion activity product of DCPD in DCPD-saturated u.f.s. was 2.4 X 10(-7), and the ion activity product of OCP in OCP-saturated u.f.s. was 4 X 10(-49), slightly above their solubility products (Ksp(DCPD) = 2.3 X 10(-7), Ksp(OCP) = 2.5 X 10(-49). The ion activity products of DCPD and OCP in u.f.s. under CO2 indicate that the concentrations of calcium and phosphate complexing agents (except bicarbonate) are quite low. The u.f.s. remained supersaturated with respect to OHAp even after 2 months of equilibration.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3105836     DOI: 10.1007/bf02555708

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  15 in total

1.  Chemistry of enamel subsurface demineralization in vitro.

Authors:  E C Moreno; R T Zahradnik
Journal:  J Dent Res       Date:  1974 Mar-Apr       Impact factor: 6.116

2.  The state of calcium and inorganic orthophosphate in human saliva.

Authors:  P Gron
Journal:  Arch Oral Biol       Date:  1973-11       Impact factor: 2.633

3.  A comparison of some effects of fluoride on apatite formation in vitro and in vivo.

Authors:  M J Larsen; A Thorsen
Journal:  Calcif Tissue Int       Date:  1984-12       Impact factor: 4.333

4.  Measurement of inhibitors of calcium phosphate precipitation in plasma ultrafiltrate.

Authors:  H S Rüfenacht; H Fleisch
Journal:  Am J Physiol       Date:  1984-05

5.  Equilibrium dialysis and ultrafiltration studies of calcium and phosphate binding by human salivary proteins. Implications for salivary supersaturation with respect to calcium phosphate salts.

Authors:  D I Hay; S K Schluckebier; E C Moreno
Journal:  Calcif Tissue Int       Date:  1982       Impact factor: 4.333

6.  A microanalytical procedure for the determination of calcium, phosphate and fluoride in enamel biopsy samples.

Authors:  G L Vogel; L C Chow; W E Brown
Journal:  Caries Res       Date:  1983       Impact factor: 4.056

7.  Circadian rhythms of blood minerals in humans.

Authors:  M Markowitz; L Rotkin; J F Rosen
Journal:  Science       Date:  1981-08-07       Impact factor: 47.728

8.  Calcification inhibitors in rat and human serum and plasma.

Authors:  J L Meyer; H Fleisch
Journal:  Biochim Biophys Acta       Date:  1984-06-15

9.  Evaluation of a new semiautomatic electrode system for simultaneous measurement of ionized calcium and pH.

Authors:  J Thode; J Wandrup; F Aas; O Siggaard-Andersen
Journal:  Scand J Clin Lab Invest       Date:  1982-09       Impact factor: 1.713

10.  Ionized calcium in normal serum, ultrafiltrates, and whole blood determined by ion-exchange electrodes.

Authors:  E W Moore
Journal:  J Clin Invest       Date:  1970-02       Impact factor: 14.808

View more
  10 in total

1.  What bridges mineral platelets of bone?

Authors:  Christian Rey; Christèle Combes
Journal:  Bonekey Rep       Date:  2014-11-12

2.  Calcium phosphate phase transformations in serum.

Authors:  N Eidelman; L C Chow; W E Brown
Journal:  Calcif Tissue Int       Date:  1987-07       Impact factor: 4.333

3.  The effects of serum and human albumin on calcium hydroxyapatite crystal growth.

Authors:  J Garnett; P Dieppe
Journal:  Biochem J       Date:  1990-03-15       Impact factor: 3.857

4.  An Octacalcium Phosphate Forming Cement.

Authors:  M Markovic; L C Chow
Journal:  J Res Natl Inst Stand Technol       Date:  2010-08-01

Review 5.  Next generation calcium phosphate-based biomaterials.

Authors:  L C Chow
Journal:  Dent Mater J       Date:  2009-01       Impact factor: 2.102

6.  Procedure for the study of acidic calcium phosphate precursor phases in enamel mineral formation.

Authors:  C Siew; S E Gruninger; L C Chow; W E Brown
Journal:  Calcif Tissue Int       Date:  1992-02       Impact factor: 4.333

7.  Occurrence of osteoblast necroses during ossification of long bone cortices in mouse fetuses.

Authors:  B Zimmermann
Journal:  Cell Tissue Res       Date:  1994-02       Impact factor: 5.249

8.  Mutual chemical effect of autograft and octacalcium phosphate implantation on enhancing intramembranous bone regeneration.

Authors:  Hisashi Ozaki; Ryo Hamai; Yukari Shiwaku; Susumu Sakai; Kaori Tsuchiya; Osamu Suzuki
Journal:  Sci Technol Adv Mater       Date:  2021-05-28       Impact factor: 8.090

9.  Properties of Calcium Phosphate Cements With Different Tetracalcium Phosphate and Dicalcium Phosphate Anhydrous Molar Ratios.

Authors:  Satoshi Hirayama; Shozo Takagi; Milenko Markovic; Laurence C Chow
Journal:  J Res Natl Inst Stand Technol       Date:  2008-12-01

10.  Microstructure and mineral composition of dystrophic calcification associated with the idiopathic inflammatory myopathies.

Authors:  Naomi Eidelman; Alan Boyde; Andrew J Bushby; Peter G T Howell; Jirun Sun; Dale E Newbury; Frederick W Miller; Pamela G Robey; Lisa G Rider
Journal:  Arthritis Res Ther       Date:  2009-10-26       Impact factor: 5.156

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.